12Jan 2025
Prognostic Value of Late gadolinium enhancement in ARD

Prognostic Value of Late gadolinium enhancement in ARD

This retrospective study of 176 autoimmune rheumatic disease (ARD) patients with suspected cardiac involvement examined the prevalence and impact of left ventricular subendocardium-involved LGE (LGEse). LGEse was present in 13% of patients, associated with reduced LV ejection fraction (50% vs. 60%) and worse outcomes, including higher rates of adverse cardiac events (32% vs. 8%). Multivariable analysis confirmed LGEse as an independent predictor of poor prognosis, emphasizing its clinical significance in ARD-related cardiac assessment.

  • #cardiology

Like

Save

Share